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Abstract
Background: Retroviral gene expression generally depends on a full-length transcript that initiates in the 5’ LTR,
which is either left unspliced or alternatively spliced. We and others have demonstrated the existence of antisense
transcription initiating in the 3’ LTR in human lymphotropic retroviruses, including HTLV-1, HTLV-2, and HIV-1. Such
transcripts have been postulated to encode antisense proteins important for the establishment of viral infections.
The antisense strand of the HIV-1 proviral DNA contains an ORF termed asp, coding for a highly hydrophobic
protein. However, although anti-ASP antibodies have been described to be present in HIV-1-infected patients, its in
vivo expression requires further support. The objective of this present study was to clearly demonstrate that ASP is
effectively expressed in infected T cells and to provide a better characterization of its subcellular localization.
Results: We first investigated the subcellular localization of ASP by transfecting Jurkat T cells with vectors
expressing ASP tagged with the Flag epitope to its N-terminus. Using immunofluorescence microscopy, we found
that ASP localized to the plasma membrane in transfected Jurkat T cells, but with different staining patterns. In
addition to an entire distribution to the plasma membrane, ASP showed an asymmetric localization and could also
be detected in membrane connections between two cells. We then infected Jurkat T cells with NL4.3 virus coding
for ASP tagged with the Flag epitope at its C-terminal end. By this approach, we were capable of showing that
ASP is effectively expressed from the HIV-1 3’ LTR in infected T cells, with an asymmetric localization of the viral
protein at the plasma membrane.
Conclusion: These results demonstrate for the first time that ASP can be detected when expressed from full-
length HIV-1 proviral DNA and that its localization is consistent with Jurkat T cells overexpressing ASP.
Background
Human lymphotropic retroviruses, such as human T-cell
leukemia virus type 1 (HTLV-1) or human immunodefi-
ciency virus type 1 (HIV-1), have evolved multiple strate-
gies to direct the synthesis of a complex proteome from a
small genome, which involves alternative splicing, inter-
nal ribosomal entry sites, ribosomal frameshifting, and
leaky scanning [1]. Retroviral genomes are transcribed
through a proviral DNA intermediate integrated into the
cell chromosome and expressed by the host transcription
machinery. All retroviral genes have been thought to be
transcribed through a single promoter located in the 5’
long terminal repeat (LTR) of the provirus. However,
early studies have described the presence of conserved
open reading frames (ORF) in the complementary strand
of the HIV-1 and HTLV-1 proviruses, suggesting the
existence of viral mRNAs of negative polarity produced
from the 3’ LTR [2,3]. More recently, we and others have
conclusively demonstrated the presence of such antisense
RNAs in cells infected with HIV-1 or HTLV-1 [4-7].
In the case of HTLV-1, the antisense strand-encoded
protein that we have termed HBZ for HTLV-1 bZIP factor
[8] is a c-Fos-like nuclear factor [9,10] that attenuates the
activation of AP-1 [11-14] and down-regulates viral tran-
scription [15,16]. In vivo studies using a rabbit model have
* Correspondence: barbeau.benoit@uqam.ca; jean-michel.mesnard@cpbs.cnrs.
fr
† Contributed equally
1Université Montpellier 1, Centre d’études d’agents Pathogènes et
Biotechnologies pour la Santé (CPBS), Montpellier, France
4Université du Québec à Montréal, Département des sciences biologiques
and Centre de recherche BioMed, Montréal, Canada
Full list of author information is available at the end of the article
Clerc et al. Retrovirology 2011, 8:74
http://www.retrovirology.com/content/8/1/74
© 2011 Clerc et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.shown that HBZ is involved in the establishment of
chronic viral infections [17], indicating that HBZ could
play a key role in the escape of HTLV-1 from the immune
system by controlling viral expression [18,19]. Interest-
ingly, we have recently demonstrated that HTLV-2
encodes an antisense protein (called APH-2 for antisense
protein of HTLV-2) that also represses viral transcription
[20].
Although all functional HIV-1 genes are thought to be
transcribed from the sense proviral DNA strand only, a
very recent study has shown that cryptic epitopes derived
from an HIV-1 antisense ORF are generated in infected
CD4+ T lymphocytes [21], confirming the production of
viral proteins from antisense transcription. Among the
different negative sense ORFs found in HIV-1 [2,6], the
asp (for antisense protein [22]) ORF, encoded by the
complementary strand to the gp120/gp41 junction of the
env gene (Figure 1A), is the most conserved and the long-
est. Moreover, its presumed ATG initiation codon is also
very well preserved. In addition, its position from the 3’
LTR is extremely similar to the hbz ORF in HTLV-1 and
the aph-2 ORF in HTLV-2. Asp codes for a highly hydro-
phobic protein [2] (Figure 1A) that has been found asso-
ciated with virions released from infected cells [22].
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Figure 1 Characterization of the HIV-1 ASP mutant proviral clone. (A) Schematic representation of the HIV-1 proviral genome. The viral
ORFs are presented based on the nature of their encoding transcripts, i.e. multiply-spliced, mono-spliced, and unspliced sense transcripts (red,
blue, and white). The antisense strand-encoded asp ORF (green) is also indicated. The reported asp coding region is further indicated below
showing the two cysteine triplets, the SH3 binding motif (PxxPxxP), and potential transmembrane regions (TM). The numbers shown indicate
amino acid positions. (B) Reduction of extracellular p24 Gag levels from 293T cells transfected with ASP-deficient HIV-1 proviral DNA. 293T cells
were cotransfected with pNL4.3WT or pNL4.3ASPmut12 and pRcActin-LacZ. Forty-eight hours after transfection, supernatants were harvested and
quantified through a p24 ELISA assay. Results are presented as the average p24 value +/- S.D. of b-galactosidase-normalized values from three
independently transfected cell samples. Cell lysates were prepared from non-transfected 293T cells (NT) or cells transfected with pNL4.3WT or
pNL4.3ASPmut12. Western blot analyses (under the histogram) were conducted on these preparations using anti-p24 and HRP-conjugated goat
anti-rabbit IgG antibodies (two independent transfections are presented per condition). (C) Analysis of WT and ASPmut12 virion morphology.
Virus particles produced from 293T cells transfected with pNL4.3WT or pNL4.3ASPmut12 were analyzed in thin-layer electron microscopy. The
black bars correspond to a scale of 100 nm.
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Page 2 of 12Moreover, the ASP protein has been described to be
recognized by antibodies present in patients infected by
HIV-1 [23]. Here, we demonstrate for the first time that
ASP is expressed in Jurkat T cells infected with a proviral
clone, with an asymmetric localization of the viral protein
at the plasma membrane.
Results
Construction and characterization of an HIV-1 ASP
mutant proviral clone
In order to study ASP, we first generated a mutated pro-
viral clone in which a stop codon was inserted in frame to
the asp ORF. This mutation resulted in termination of
ASP at amino acid 12 of the published sequence [2] with-
out altering the amino acid composition of the Env protein
encoded on the sense strand. This resulting pNL4.3ASP-
mut12 construct was next transfected in 293T cells and
compared for p24 production to 293T cells transfected
with wild type (WT) pNL4.3. Transfected cells showing
comparable transfection efficiency were then selected to
evaluate their levels of extracellular viral capsid proteins.
Interestingly, 293T cells transfected with the mutated pro-
viral DNA showed lower extracellular p24 levels when
compared to results obtained with the parental wild-type
proviral DNA (Figure 1B). To determine whether p24
expression was also reduced intracellularly, cell lysates
from transfected cells were analysed by Western blotting.
As shown in Figure 1B, intracellular p24 levels were not
affected by the ASP mutation. These data were confirmed
in three different experiments, and analyses of p24 signals
by densitometry further demonstrated equivalent p24
levels in cells transfected with the two tested NL4.3 pro-
viral DNA (see the additional file 1, figure S1). Western
blot analyses were also performed on the same preparation
by using human anti-HIV-1 serum and confirmed that
intracellular levels of viral proteins were not affected (data
not shown). The effect of the mutation was also investi-
gated on the structure of the viral particle by electron
microscopy analysis, and normal-sized mature virions
were found in preparations of WT and ASPmut12 parti-
cles (Figure 1C). The presence of unambiguous cone-
shaped nucleoids was also observed in WT and ASPmut12
viruses. In addition, when Jurkat and Sup-T1 cells were
infected with WT or ASPmut12 viruses, no significant
differences in the levels of extracellular p24 were detected
at different times post-infection between both viruses
(Figure 2).
The HIV-1 ASP protein localizes to the plasma membrane
To better characterize the ASP protein, its expression and
localization were analyzed in Jurkat cells. Analysis of its
amino acid sequence reveals a highly hydrophobic protein.
Hydropathy and immunogenicity plots demonstrate a
minimal number of soluble regions and suggest two trans-
membrane domains extending from amino acid 63 to 84
and amino acid 146-167 (Figure 1A). In its N-terminal
region, the ASP sequence also revealed the presence of
two conserved cysteine triplets (with a potential palmitoy-
lation site for the first one) and two SH3-binding motifs
with a typical proline rich sequence with a PxxP minimal
core (Figure 1A). We thus presumed that the presence of
potential transmembrane domains could lead to mem-
brane localization of the protein.
To test this hypothesis, Jurkat T cells were transfected
with an ASP expression vector in which ASP was
tagged with the Flag epitope at its N-terminal end. The
transfected cells were co-stained with both FITC-Co-Tx
(which binds to GM1 ganglioside, a component of the
cell plasma membrane) and anti-Flag antibody and sub-
sequently analysed on a confocal microscope (Figure 3).
Image merging of both fluorescent signals confirmed
the localization of ASP to the plasma membrane. The
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Figure 2 HIV-1 infection of T cells is not affected by the absence of ASP. HIV-1 viral particles harvested from 293T cells transfected with
pNL4.3WT or pNL4.3ASPmut12 were used to infect Jurkat (A) and Sup-T1 (B) cells. Extracellular p24 levels were quantified on supernatant from
triplicate infected samples and are presented as the mean value +/- S.D.
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Page 3 of 12same approach was performed with cells transfected
with the pcDNA-Flag-ASPΔATG expression vector, in
which the initiation codon of Flag-ASP was replaced by
a stop codon. No specific fluorescent signal was
detected with the anti-Flag antibody as illustrated in
Figure 3.
ASP localizes differently at the membrane of Jurkat cells
Although our results showed that ASP localized to the
plasma membrane, two distinct sites were observed. In
addition to its unpolarized localization to the plasma
membrane (Figure 4A), ASP also showed an asymmetric
distribution in ASP-expressing Jurkat cells (Figure 4B).
Polarization of ASP to the plasma membrane was found in
44% ± 5 of transfected cells while unpolarized distribution
corresponded to 44% ± 3 (Figure 4E). Moreover, ASP
occasionally presented a strong localization into mem-
brane protrusion (Figure 4C) corresponding to 12% ± 2 of
transfected cells (Figure 4E). Such staining patterns were
not observed in Jurkat cells tranfected with the negative
control pcDNA-Flag-ASPΔATG (data not shown). We
also analyzed the subcellular localization of an ASP
mutant, called ASPmut66, corresponding to the first 65
amino acid residues of ASP, which were thus devoid of
both potential transmembrane domains. Compared to the
wild type, this mutant showed a different staining profile
since ASPmut66 was not localized to the plasma mem-
brane (Figure 4D).
Using this approach, we also detected ASP in membrane
connections between two cells as shown in Figure 5A.
Based on these results, we further analyzed the distribu-
tion of ASP in transfected Jurkat cells seeded on polyly-
sine-covered glass slides at high density, thus favouring
cell-to-cell interactions. Interestingly, an intense staining
of ASP was found in membrane projections (Figure 5B).
Moreover, the ASP staining can highlight a thin and long
connection between neighbouring cells (Figure 5C). When
similar analyses were performed in Jurkat cells transfected
with pEGFP, the fluorescent signal demonstrated a diffuse
pattern present not only in intercellular connections, but
also in all cellular compartments (Figure 5D). The Scrib
(Scribble) protein is a cell membrane-associated protein
involved in the regulation of the asymmetric distribution
of proteins in T cells [24,25]. We then compared the loca-
lization of ASP with hScrib in transfected Jurkat cells
seeded on polylysine-covered glass slides. As shown in the
additional file 2, figure S2, ASP co-localized with endogen-
ous hScrib in membrane projections.
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Figure 3 HIV-1 ASP localizes to the membrane. Jurkat cells were transfected with pcDNA-Flag-ASP expressing ASP tagged with the Flag
epitope to its N-terminal end or with pcDNA-Flag-ASPΔATG. Localization of ASP to the membrane was visualized by confocal microscopy using
FITC-Co-Tx and immunostaining with a primary anti-Flag antibody, followed by a secondary antibody coupled to Alexa Fluor 568. Nuclei were
labelled with Hoechst. White bars correspond to a scale of 10 μm.
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Figure 4 Cellular localization of WT ASP and ASP-mut66 in transfected Jurkat T cells. Jurkat cells transfected with pcDNA-Flag-ASP (A-C) or
pcDNA-Flag-ASPmut66 (D) were layered on glass slides, fixed, permeabilized, and stained with fluorescence-labelled antibodies as described in
Figure. 3. The morphology of the cell was assessed by Normaski differential interference contrast (NDIC). White bars correspond to a scale of
10 μm. (E) Percentage of the total transfected cells with ASP showing an unpolarized distribution (white bar), a polarized location (grey bar), or a
localization into membrane protrusion (hashed bar). A total of 206 cells from three separate experiments were scored.
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Page 5 of 12ASP is expressed in infected Jurkat T cells
Before analyzing the expression of ASP in infected cells,
we first compared 5’-LTR-driven sense transcription
with the 3’-LTR antisense transcriptional activity in
infected Jurkat cells up to 48 hours post infection (hpi).
For this experiment, we made use of previously
described proviral DNA constructs containing the luci-
ferase reporter gene inserted in the nef coding sequence,
WT ASP
NDIC NDIC + anti-Flag anti-Flag
WT 
ASP
WT ASP
NDIC + EGFP  NDIC EGFP
A
B
C
D
Figure 5 ASP localization in membrane connection. Jurkat cells transfected with pcDNA-Flag-ASP (A-C) or pEGFP (D) were layered on glass
slides (A) or seeded at high density on polylysine-covered glass slides (B-D). The localization of ASP was analyzed as described above. The
morphology of the cell was assessed by NDIC. White bars correspond to a scale of 10 μm.
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Page 6 of 12either in the sense (pNL4.3LucE
-R
-) or antisense direc-
tion (pNL4.3AsLucE
-R
-) [7,26]. Both molecular proviral
clones were separately cotransfected with a VSVg
expression vector in 293T cells to produce virions pseu-
dotyped with the VSV envelope. Jurkat cells were subse-
quently infected with an identical infectious viral titer
for both types of virions (MOI = 2). As depicted in
Figure 6, at 48 hpi, luciferase activity was notably lower
in Jurkat cells infected with NL4.3AsLucE
-R
- virions
when compared to cells infected with NL4.3LucE
-R
- vir-
ions. Nonetheless, a continuous increase in luciferase
activity was observed for both viruses and the 3’-LTR
antisense activity was the highest at 48 hpi.
Next, to detect ASP in infected Jurkat cells, we gener-
ated the proviral clone, pNL4.3ASP-Flag, in which ASP
was tagged with the Flag epitope at its C-terminal end
(Figure 7A); the presence of this tag resulted in termina-
tion of Env at amino acid 408. Therefore this molecular
proviral clone was cotransfected with a VSVg expression
vector in 293T cells to produce pseudotyped virions able
to infect Jurkat cells. As determined by our analysis on
the 3’-LTR transcriptional activity, expression and locali-
zation of ASP were analyzed by fluorescence microscopy
a tt h eo p t i m a lt i m e ,i . e .4 8h p i .A l t h o u g hA S Pw a s
detected in very few cells, its polarized localization was
again confirmed in infected cells (Figure 7B). As negative
control, we generated the mutant proviral DNA clone,
pNL4.3ASPmut12-Flag, in which the expression of ASP-
Flag was inhibited by introducing a stop codon at amino
acid 12 of ASP as described above (see Figure 1). No
staining was detected in Jurkat cells infected with viruses
derived from this mutated construct, although Gag-
positive cells were observed as frequently as the other
tested proviral DNA (Figure 7C and the additional file 3,
figure S3).
Taken together, our results demonstrate for the first
time that ASP is detected when expressed from full-
length proviral DNA and that its localization is consis-
tent with Jurkat cells overexpressing ASP.
Discussion
The existence of bidirectional transcription from retro-
virus LTRs has been initially suggested based on the
identification of conserved ORFs in the antisense strand
of their genome, and its demonstration has been mostly
focused on human lymphotropic retroviruses. An initial
study by Miller [2] had addressed this possibility in HIV-
1, and similar ORFs had subsequently been identified on
the antisense strand of other retroviruses like HTLV-1
and feline immunodeficiencyv i r u s[ 3 , 2 7 ] .H o w e v e r ,t h e
existence of antisense transcription in retroviruses was
controversial until the characterization of HBZ in 2002
[8]. Since then, antisense transcription has also been con-
firmed in HTLV-2 [20] and in gammaretroviruses such
as murine leukemia virus [28]. Over the years, transcrip-
tion initiation has been demonstrated to be a complex
process and, in fact, most promoter regions associated to
active mammalian genes can transcribe in both sense and
antisense directions [29,30]. It seems that retroviruses
have developed a mechanism to hijack the bidirectional
transcription machinery to produce proteins from sense
and antisense transcription. The presence of coding
genes can probably stimulate elongation by RNA poly-
merase II either in the sense direction from the 5’ LTR,
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Figure 6 HIV-1 antisense transcription in infected Jurkat T cells. Jurkat cells were infected with NL4.3LucE
-R
- or NL4.3AsLucE
-R
- virions
pseudotyped with VSVg, and lysed at different time points post-infection and luciferase activity was subsequently measured. Luciferase activities
represent the mean value of three measured samples +/- S.D., performed with two different virus preparations for each proviral DNA construct.
Luciferase activities are presented on a logarithmic scale. CTL corresponds to levels measured in non-infected cells.
Clerc et al. Retrovirology 2011, 8:74
http://www.retrovirology.com/content/8/1/74
Page 7 of 12or in the antisense direction from the 3’ LTR. Such a
mechanism allows the synthesis of a complex proteome
from the proviral genome integrated into the cell
chromosome.
Although the synthesis of proteins from antisense tran-
scripts has been clearly demonstrated in the case of
HTLV-1 and -2 [8,20], this possibility remains debated
for HIV-1. Antisense RNA was however identified in var-
ious cell lines chronically infected with HIV-1 [7,23,31].
By RACE analyses, we have recently identified several
transcription initiation sites near the 5’ border of the 3’
LTR and a polyA signal located at 2.4 kb distance from
the ASP stop codon [7]. Such transcripts are potentially
templates encoding the ASP protein. Indeed, it has been
found that translation of the in vitro-synthesized anti-
sense RNA yielded a protein with an apparent molecular
weight of 19 kDa in SDS-PAGE [23] corresponding to
the theoretical molecular weight of ASP. Moreover, this
report further described the presence of antibodies
against ASP in several sera of HIV-1-infected patients
[23]. Interestingly, very recent results support the notion
that epitopes derived from antisense transcripts serve as
CD8 T-cell targets in HIV-1 infection [21]. Taken
together, all these data suggest that the HIV-1 ASP pro-
tein should be expressed in vivo. However, its detection
through Western blot analysis from cellular extracts has
not yet been possible. Different reasons can explain the
lack of detection of the ASP protein. First of all, antisense
retroviral proteins are poorly expressed in vivo [8,20].
Levels of antisense transcripts can be 30 to 1000 folds
lower than that of sense transcripts [7]. In addition, the
negative effect of certain sequences on RNA stability is
well known in the case of HIV-1 sense transcripts. For
instance, Vpu and Vif proteins are poorly expressed from
expression vectors and generation of codon-optimized
viral cDNAs can overcome this limitation [32]. Indeed,
ASP expression can be improved by codon optimization
of its coding sequence (B.B., personal communication). A
second concern for the detection of ASP is related to its
structure. In this paper, we demonstrate that ASP is loca-
lized to the plasma membrane. This localization is con-
sistent with the predicted structure of ASP, which is a
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Figure 7 ASP expression in infected or transfected Jurkat T cells. (A) Schematic representation of the pNL4.3ASP-Flag vector, which
corresponds to a molecular proviral DNA in which ASP was tagged with the Flag epitope at its C-terminal end. Jurkat cells were infected with
NL4.3ASP-Flag (B) or NL4.3ASPmut12-Flag (C) virions pseudotyped with VSVg and ASP localization was analyzed as described above. The
morphology of the cell was assessed by NDIC. White bars correspond to a scale of 10 μm.
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Page 8 of 12highly hydrophobic protein displaying two potential a-
helical transmembrane segments. Furthermore, the
ASPmut66 protein (deleted of both potential transmem-
brane domains) did not localize to the plasma membrane,
confirming the predicted structure. Its inherent mem-
brane-bound nature makes the characterization of this
protein particularly difficult and likely requires special
experimental conditions [33]. In addition, characteriza-
tion of membrane proteins is very difficult because they
are usually poorly abundant. All these issues concerning
membrane proteins explain the great disparity between
current knowledge of soluble versus membrane proteins.
In this paper, by using a strategy different from Wes-
tern blot analyses, we clearly demonstrate for the first
time that ASP is expressed in infected Jurkat T cells. By
using fluorescence microscopy, we have first character-
ized the distribution of ASP tagged with the Flag epitope
in Jurkat cells. We then compared ASP localization in
these conditions with that in Jurkat cells infected with a
proviral clone in which ASP was tagged with the Flag epi-
tope to its C-terminus. We could indeed confirm the
polarized localization profile of ASP in infected cells. As
expected, this staining pattern was abolished by introdu-
cing a stop codon in the asp ORF. By using immunoelec-
tron microscopy, expression of ASP has been previously
analyzed in HIV-1-infected Sup-T1 cells and the viral
protein appeared to concentrate in the nucleus and in
the cytoplasm [22]. ASP was also detected in the acti-
vated ACH-2 cell line, a chronically infected T cell line.
In this study, ASP localized in several cell compartments
including the nucleus, the nucleolus, and the mitochon-
dria but not at the plasma membrane [22]. The presence
of ASP was detected in the cytoplasm and the nucleus in
the vicinity of the cell membranes. However, the nucleo-
lar localization of ASP is unexpected since the nucleolus
is a non-membrane bound structure. In our infection
experiments, we have never detected ASP associated to
the nucleus or the nucleolus. We are unable to explain
this discrepancy between the two approaches.
At the moment, the function of ASP remains myster-
ious. In our studies, we have noted a significant reduction
in the level of extracellular p24 production from 293T
cells transfected with the mutant pNL4.3ASPmut12 com-
pared to the parental wild-type proviral DNA, but we have
been unable to reproduce these results in Jurkat and Sup-
T1 cells infected with virions produced with the same
mutant. This difference could be explained by the method
used to introduce the viral genome into cells. In the case
of infection, integration of retroviral DNA into the host
genome is an obligatory step for viral protein expression.
Depending on the chromosomal location of the integrated
provirus, LTR-mediated transcription may vary from 0- to
70-fold. At the moment, we do not know whether ASP is
more expressed in transfected 293T cells than in infected
Jurkat cells. Similarly, regulation of ASP expression during
viral life cycle remains unclear. In the case of HTLV-1,
kinetic analysis revealed that antisense transcription was
expressed at a low level early after infection and continued
to increase before reaching a plateau, showing an inverse
correlation between sense/antisense transcription over
time [34]. We do not observe a similar trend in the case of
HIV-1 but experiments are currently in progress to study
the regulation of antisense transcription in primary cells.
It is thereby difficult to draw conclusions concerning the
function of ASP.
Conclusion
We demonstrate for the first time that ASP can be pro-
duced in infected Jurkat T cells. The in vivo detection of
ASP gives a novel tool to better understand how HIV-1
is involved in the development of immunodeficiency.
Methods
Plasmids and antibodies
The pNL4.3 HIV-1 proviral DNA was obtained from the
NIH AIDS Research and Reference Reagent Program
(Germantown MD). To produce the pNL4.3-ASPmut12
construct, a NdeI/BamHI fragment containing the asp
sequence was first cloned in a similarly digested pGL3
basic vector. Using primers 24-8 (5’-GTTGCAACTCA-
CAGTCTGGGGCAT-3’) and 24-7 (5’-AGATGCTGTT-
GAGCCTC AATAGCC-3’; the mutated nucleotide is
indicated in bold), reverse PCR was used to mutate the
c y s t e i n er e s i d u ei np o s i t i o n1 2i n t oas t o pc o d o n( T G C
into TGA). Sequencing of the entire NdeI/BamHI frag-
ment confirmed the specific mutation after which the frag-
ment was cloned back in the pNL4.3 DNA to replace the
wild type segment. The pNL4.3LucE
-R
- vector (containing
the luciferase reporter gene and deficient for Env and Vpr
synthesis [26]) was generously provided by Dr N.R.
Landau. The pNL4.3AsLucE
-R
- vector has previously been
described [7]. The Flag-ASP, Flag-ASPΔATG, and Flag-
ASPmut66 cDNA fragments were generated by PCR
amplification using Deep Vent DNA polymerase and spe-
cific sense and antisense primers. The nucleotide sequence
coding for the Flag epitope (DYKDDDDK) has been
inserted in the sequence of the sense primer. The synthe-
sized cDNA was inserted into the BamHI/EcoRI cloning
sites of the linearized pcDNA3ZEO vector. To generate
the pNL4.3ASP-Flag construct, the NL4.3-derived NdeI/
BamHI fragment cloned in pGL3 basic was used to add
NcoI and XbaI sites and displace the stop codon at the 3’
end of the ASP ORF by reverse PCR with the following
primers: 5’-GCTCTAGATAGAAAAATTCCCCTCCA-
CAATTAAAACTG-3’ (sense) and 5’-GTCCATGGCTG-
TAATTCAACACAACTGTTTAATAGTAC-3’ (anti-
sense). Primers permitting the addition of a Flag tag at the
COOH end of the ASP ORF, 5’-CATGGGACTACA
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GACTTGTCGTCGTCGTCCTTGTAGTCC-3’ (anti-
sense), were annealed and inserted in frame at the 3’ end
of the ASP ORF after NcoI/Xba I digestion. The resulting
Flag-tagged ASP ORF was reinserted in the NL4.3 proviral
DNA using the NdeI/BamHI sites. The 5’LTR-deleted
pNL4.3ASP-Flag Δ5’LTR construct was then generated by
NarI digestion and self ligation. pRcActin-lacZ contains
the b-galactosidase gene under the control of the human
b-actin promoter.
Mouse anti-p24 antibody was purchased from Abcam,
while goat anti-mouse IgG was bought from GE Health-
care. Mouse anti-Gag KC57-RD1 antibody was pur-
chased from Beckman-Coulter. We have obtained the
mouse anti-Flag antibody from Sigma and the rabbit
anti-hScrib (H-300) antibody from Santa Cruz Biotech-
nology, Inc.
Transfection, infection, and detection of viral p24 capsid
antigen
Transfection experiments in 293T cells were conducted
as previously described [35]. Briefly, 293T cells (3 × 10
5)
were plated 24 h prior to transfection in a 6-well plate
and were next transfected through the calcium phosphate
protocol with 3 μg wild-type or ASP-deficient pNL4.3
proviral DNA construct along with 0.5 μg pRcActin-lacZ
(used to normalize transfection experiments). At 48 h
post-transfection, supernatants were harvested and levels
of the HIV-1 p24 capsid protein was evaluated by a p24-
specific ELISA assay as previously described [36]. All
experiments were performed in triplicates and final p24
levels are represented as the average of independent tri-
plicate transfection experiments after b-galactosidase
normalization. Jurkat and Sup-T1 cells (1 × 10
6 cells)
were infected with harvested wild-type and ASP-deficient
NL4.3 viruses (100 ng p24) in RPMI supplemented with
10% FCS. Extracellular p24 levels were quantified by
ELISA at days 3, 7, 10 and 14, and represent the mean
values +/- S.D of three independently infected samples.
Western blot
Transfected 293T cells were washed in PBS and proteins
were isolated in a lysis buffer (50 mM, Tris-HCl pH 7.5,
150 mM Nacl, 0.5% NP-40, and protease inhibitor cock-
tail in tablets). Protein concentrations were then quanti-
fied with the BCA protein assay (Thermo Fisher Scientic
Inc.). Cellular extracts were migrated on an 8.5% SDS-
PAGE and transferred on a PVDF membrane. Mem-
branes were next blocked in 3% BSA and incubated
with a polyclonal anti-p24 antibody (1/1000) and were
further incubated with horseradish peroxidase-conju-
gated goat anti-rabbit antibody (1/1000). Signals were
detected with the BM chemiluminescence blotting sub-
strate kit (Roche Diagnostics) and membranes were
subsequently exposed on an ECL high performance che-
miluminescence film (Amersham Biosciences). Densito-
metric analyses were conducted on three independent
Western blot analyses from these transfected cells and
mean values +/- S.D. were determined.
Electron microscopy analysis
Cells were fixed in situ with 2.5% glutaraldehyde in 100
mM cacodylate buffer pH 7.4 for 3 h at 4°C. After three
washes in cacodylate buffer, cells were postfixed with
2% osmium tetroxide for 1 h at room temperature and
washed in cacodylate buffer. A third fixation in 0.5%
tannic acid was performed at room temperature. After
extensive washes in 0.1 M Sorensen phosphate buffer
pH 7.2, cells were included in a fibrin clot. Cells were
then dehydrated and embedded in epony resin (Embed-
812; Electron Microscopy Sciences). Sections were coun-
terstained with uranyl acetate and lead citrate alkaline
and examined with the transmission electron micro-
scope Hitachi H7100 TEM.
Fluorescence microscopy analysis
Jurkat cells were cultured in RPMI supplemented with
10% FCS. For transient-transfection assays, cells (10
6)
were transfected with 2 μg plasmids with the device
Nucleofector II according to the manufacturer’s instruc-
tions (Amaxa Biosystems, Lonza). After 48 h, cells were
pelleted, washed twice in PBS and overlaid for 30 min at
37°C on glass slides coated or not with polylysine. Cells
were then fixed with 4% formalin for 10 min, followed
by a treatment of 5 min with NH4Cl 5 mM to remove
excess of formaldehyde. Cells were next permeabilized
with 0.1% Triton for 7 min. Fixed cells were subse-
quently incubated with a blocking solution (PBS con-
taining 5% FCS) and then with the primary antibody
(mouse anti-Flag M2 antibody; Sigma) for 1.5 h at 37°C.
After several washes with PBS, the cells were incubated
with the secondary antibody coupled to Alexa Fluor 568
(Invitrogen) for 45 min at room temperature. If neces-
sary the nuclei were stained with Hoechst (Sigma). In
certain experiments, cells were stained with fluorescein
isothiocyanate-conjugated cholera toxin B (FITC-Co-Tx;
Sigma) by incubating the cells with 5 μg/ml of FITC-
Co-Tx overnight at 4°C before fixation. Coverslips were
mounted with Prolong GOLD (Invitrogen) for direct
observation as previously described [25]. Fluorescence
images were acquired by a fluorescence microscope
(model DC250 Leica), and analysis of the green, red,
and blue fluorescence in colocalization experiments was
performed with a SP2 Leica confocal microscope.
Infection and luciferase assays
To produce the pseudotyped HIV-1 particles, 293T cells
were plated 16 h before transfection (7 × 10
6 cells per
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2 flasks) and then transfected with
the different pNL4.3 proviral DNA (30 μg) and the Vesi-
cular Stomatitis Virus envelope (VSVg) expression vec-
tor (18 μg) using the jetPEI™ transfection reagent
(Qbiogene) according to manufacturer’s instructions.
Five hours after transfection, cells were cultured for 48
h in serum-free DMEM. Viruses were then collected by
filtering the culture media through a 0.45 μmp o r es i z e
cellulose acetate membrane and the filtrate was spun
down at 100000 g at 4°C during 2 h. After centrifuga-
tion, the supernatant was removed and the viral pellet
was resuspended in 100-500 μl RPMI supplemented
with 5% FCS. Virus stocks were then aliquoted and fro-
zen at -80°C for future use. All virus stocks underwent a
single freeze-thaw cycle before use in infection studies.
Infectious virus titer was determined by infecting Jurkat
cells (10
6/well in a 24-well plate) with two-fold serial
dilution of virus stocks. At 48 hours post-infection (hpi),
the percentage of infected cells was determined by intra-
cellular staining of HIV-1 Gag with KC57-RD1 antibo-
dies followed by analysis with an Epics XL flow
cytometer (Beckman-Coulter). Jurkat cells (10
6/well)
were infected with an identical multiplicity of infection
(MOI = 2) for virus stocks. Luciferase assays were per-
formed in an automated luminometer (Contro XS
3
LB960, Berthold technologies) with the Genofax A kit
(Yelen, Ensue la Redonne) according to the manufac-
turer’s instructions.
Additional material
Additional file 1: Figure S1. Analyses of p24 signals by
densitometry. Densitometric analyses were used to quantify p24 levels
and are expressed as a ratio of p24 over GAPDH. Mean values +/- S.D.
were calculated from three independent transfection and Western blot
analyses.
Additional file 2: Figure S2. ASP colocalizes with hScrib. Microscopy
analysis of endogenous hScrib was performed in Jurkat cells transfected
with pcDNA-Flag-ASP already shown in Figure. 5C. Jurkat cells were
stained with the rabbit anti-hScrib antibody and goat anti-rabbit
immunoglobulin G antibody coupled to FITC while the localization of
ASP was analyzed as already described. For localization, analysis of green
(anti-hScrib), red (anti-Flag), and merged fluorescence was performed
with a confocal microscope. Nuclei were labelled with Hoechst. White
bars correspond to a scale of 10 μm.
Additional file 3: Figure S3. Gag expression in Jurkat T cells
infected with NL4.3ASPmut12-Flag. Jurkat cells were infected (A) or
not (B) with NL4.3ASPmut12-Flag and infection was confirmed by
intracellular staining of HIV-1 Gag with KC57-RD1 antibodies and
analyzed as already described.
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